The Artificial Intelligence & Cancers Association is the result of a unique public – private partnership that brings together the French National Cancer Institute (INCa), the Health Data Hub, the Health Industry Alliance for Research and Innovation (ARIIS), France Biotech and 9 of the world’s leading health industry companies in oncology.
Our ambition can be summed up in one sentence : to transform data into real innovations for patients. To achieve this ambition, the AI & Cancers Association is multiplying projects, testing national databases on industrial issues and working on their admissibility to regulatory authorities, in particular through a long-term dialogue with the French National Authority for Health (HAS).
The creation of this partnership between the public and private sectors demonstrates a shared will to accelerate cancer research and to make France a landmark ecosystem that is attractive at the global level.
The IA & Cancers Association supports each project leader from the ideation phase to the results. Projects are selected by our Board of Directors on the basis of three broad families of criteria : the innovative nature of the project, its potential for the national ecosystem and its contribution to the influence of the Association.
Projects may focus on rare, frequent, poor-prognosis or pediatric cancers, etc., and address issues related to patient journey, personalized medicine, search for new biomarkers…
For the Janssen laboratories, innovation means openness, collaboration and cooperation. To achieve this, the Janssen laboratories believe it is important to bring together the power
Representatives of the Artificial Intelligence & Cancers Association, the French National Cancer Institute and AstraZeneca were honored to present at ASCO 2024 the results of
In this third video about the French National Cancer Institute, you’ll meet Christian Puppinck, a patient representative who brings experience, advice and the point of
Filière Intelligence Artificielle & Cancers
